CA2580857A1 — Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
Assigned to Xenon Pharmaceuticals Inc · Expires 2006-09-28 · 20y expired
What this patent protects
Methods of treating an SCD-mediated disease or condition in a mammal, preferebly a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): where x, y, G, J, K, L, M, W, R2, R3, R5 , R5a, R6, R6a, R7, R7a, R8 and R8a …
USPTO Abstract
Methods of treating an SCD-mediated disease or condition in a mammal, preferebly a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): where x, y, G, J, K, L, M, W, R2, R3, R5 , R5a, R6, R6a, R7, R7a, R8 and R8a are difined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.